US5869600A - Film forming antiperspirant polymers - Google Patents

Film forming antiperspirant polymers Download PDF

Info

Publication number
US5869600A
US5869600A US08/722,591 US72259196A US5869600A US 5869600 A US5869600 A US 5869600A US 72259196 A US72259196 A US 72259196A US 5869600 A US5869600 A US 5869600A
Authority
US
United States
Prior art keywords
hal
topical composition
group
carbon atoms
quaternised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/722,591
Inventor
Brian E. Causton
Frederick C. Baines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gillette Co LLC
Original Assignee
Gillette Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9406854A priority Critical patent/GB9406854D0/en
Priority to PCT/GB1995/000800 priority patent/WO1995027473A1/en
Priority to CN95192934A priority patent/CN1147763A/en
Priority to AU21448/95A priority patent/AU2144895A/en
Priority to CA 2186594 priority patent/CA2186594C/en
Priority to BR9507302A priority patent/BR9507302A/en
Priority to US08/722,591 priority patent/US5869600A/en
Application filed by Gillette Co LLC filed Critical Gillette Co LLC
Assigned to GILLETTE COMPANY, THE (A DELAWARE CORPORATION) reassignment GILLETTE COMPANY, THE (A DELAWARE CORPORATION) ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAINES, FEDERICK C., CAUSTON, BRIAN E.
Priority to US09/144,864 priority patent/US5948882A/en
Application granted granted Critical
Publication of US5869600A publication Critical patent/US5869600A/en
Assigned to THE GILLETTE COMPANY LLC reassignment THE GILLETTE COMPANY LLC MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: THE GILLETTE COMPANY, THE GILLETTE COMPANY LLC
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8117Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8135Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/24Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24479Structurally defined web or sheet [e.g., overall dimension, etc.] including variation in thickness
    • Y10T428/24612Composite web or sheet
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31551Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]

Definitions

  • This invention relates to certain film-forming polymers and to their use as antiperspirants.
  • ACH basic aluminium chloride
  • WO 93/24105 describes topical antiperspirant compositions consisting essentially of an effective antiperspirant amount of a non-toxic water-insoluble occlusive film-forming polymer.
  • a non-toxic water-insoluble occlusive film-forming polymer examples include alkyl olefinic acid amide/olefinic acid or ester copolymers, alone or in combination with a PVP-linear alpha-olefin copolymer or other water-repellent polymer.
  • These compositions are said to function as antiperspirants by the formation of a water-insoluble occlusive film on the skin, which reduces under-arm perspiration. They are described for use with ACH or alone.
  • a film-forming polymer comprising units of the formulae: ##STR1## wherein X is a group which can be directly quaternised by reaction with an amine, or itself comprises a quaternisable nitrogen atom;
  • X'--Q is quaternised X, where Q is the quaternised nitrogen group and X' may be non-existent;
  • Q has at least one quaternised nitrogen atom having at least one substituent thereon which is hydrophobic and contains at least 8 carbon atoms;
  • Y is any atom or group which cannot be directly quaternised and does not comprise a quaternisable nitrogen atom
  • R is hydrogen or alkyl (the alkyl preferably being C 1 to C 6
  • n and p can each be 0 or an integer
  • (n+m+p) is from 20 to 2000, preferably 20 to 1000;
  • n/(n+m+p) % is from 1% to 100% preferably 25% to 95%; and wherein the polymer can contain two or more different units of formula I, formula II and/or formula III.
  • an antiperspirant composition which comprises, as the main or only active antiperspirant ingredient, a film-forming polymer of the invention and a cosmetically acceptable non-aqueous carrier therefor which may be in admixture with a minor amount of water.
  • X is a group which either contains a quaternisable nitrogen atom, or which can be directly quaternised by reaction with an amine.
  • the amine(s) can itself be in quaternised form if desired.
  • compositions of the invention can contain a small amount (i.e. usually less than 5% by weight) of an aluminium antiperspirant, but in general the presence of aluminium antiperspirants reduces the efficacy of the compositions and we prefer the compositions to be substantially free from aluminium.
  • the compositions can be formulated into aerosol, solid stick, roll-on, gel or cream formulations, for example.
  • European patent specification no. 0141269 describes certain polyvinyl alcohol polymers having oxylinked pendant quaternary ammonium or tertiary amine groups, as aids in reducing moisture loss when applied to skin as conditioning lotions or ointments in cosmetic and pharmaceutical formulations.
  • moisture loss polymers of this type function by forming a thin film on the surface of the skin. This film reduces transepidermal loss of moisture.
  • This is a different effect from the antiperspirancy function of ACH.
  • An antiperspirant functions to stop or significantly reduce the aqueous discharge from sweat ducts, and this is two or more orders of magnitude greater than transepidermal moisture loss.
  • the polyvinyl alcohol derivatives are used in amounts from 0.5-5% by weight of antiperspirant compositions containing conventional amounts of ACH, one example being 4% of the polymer in a composition containing 57% Al Zr tetrachloro-hydrex-Gly Rezol 36G (Reheis). This is quite different from the compositions of the present invention where amounts of ACH greater than about 5% tend to cause a reduction of antiperspirant efficacy.
  • polyvinyl alcohol polymers described in EP-A-0141269 are soluble or dispersible in water so that they will function to reduce transepidermal loss and be compatible with conventional aqueous-based cosmetic and personal care products.
  • the polymers used in the present invention are hardly soluble or dispersible in water at all, and require an alcoholic or other non-aqueous solvent carrier. Indeed, dispersions are unstable in the presence of significant amounts of water.
  • the quaternary nitrogen atoms have a hydrophobic substituent of relatively large size, i.e. at least C 8 .
  • the effect of this hydrophobic substituent is to cause the polymer to change shape in the presence of any water which will be present during use of the polymer as an antiperspirant. It is believed that the change of shape is such as to express the ionic groups and this significantly improves the substantivity towards human skin.
  • the polymers of the invention thus have good substantivity and also show a marked antiperspirant effect.
  • a preferred substituent for the quaternary nitrogen group is a substituted or unsubstituted hydrocarbyl group containing from 8 to 24 carbon atoms. Possible substituents include, for example, halogen, amino, nitrate, hydroxyl or aryl substituents. More preferably, the hydrocarbyl group is a linear saturated group, most preferably an alkyl group, especially of 12 to 18 carbon atoms, e.g. dodecyl or stearyl. It is to be understood that by "antiperspirant” we mean a substance which when applied to the skin as an antiperspirant reduces wetness by at least 20%. (Federal Register, Oct. 10th 1978 (43 FR 46694) and Federal Register, Aug. 20th 1982 (162 FR 36492).)
  • antiperspirants are usually formulated as roll-ons, sticks, aerosols, gels or creams.
  • the active antiperspirant be in solution.
  • a dispersion can be used provided it is relatively stable.
  • the film-forming polymers used in the present invention are generally not soluble in water, they are dissolved or dispersed in a non-aqueous cosmetically acceptable carrier.
  • the amount of film-forming polymer is generally from 1% to 20% by weight, preferably from 6% to 10% by weight.
  • suitable carriers include alcohols such as ethanol, glycols such as propylene glycol, dipropylene glycol, butylene glycol, triols such as glycerol, propylene carbonate and volatile silicones including, for example, cyclic silicones, linear silicones and low molecular weight dimethicones.
  • Some water can be included provided that the composition remains as a solution or is a stable dispersion. The addition of too much water will destabilise the dispersions.
  • the amount of water which can be tolerated varies from polymer to polymer and with the non-aqueous carrier, and may be as little as 1% up to amounts of 30% or more. It will, however, always be less than the amount of non-aqueous carrier, i.e. it is present in minor amount relative thereto. In any particular case, routine trials will indicate the limits. It is preferred that, in the final formulation, some water be present.
  • the disperse phase be from 5 to 10 micrometres in size.
  • film-forming polymer is not critical.
  • X' is an alkylene carbonyl oxy group (--R 4 .CO.O--) a carbonyl oxyalkylene group (--CO.O.R 4 --), or an arylene (e.g. --C 6 H 4 --) or aralkylene (e.g. --C 6 H 4 --R 4 --) group.
  • X' has the formula --O.CO.CH 2 --(the oxygen being attached to the --CR-group) and R is hydrogen or methyl; or X' is a carbonyloxyethylene-oxyethylene group (the carbon being attached to the --CR-group) and R is methyl; or X' is a benzyl group (the benzyl --CH 2 being attached to Q) and the R is hydrogen.
  • These polymers can be variously derived from, for example, polyvinylalcohol, haloalkyl polystyrenes and polyhydroxyalkyl methacrylates. Halogens can be introduced into hydroxy side-chains using chloroacetate, and the halogen then quaternised.
  • each R 4 is independently an alkylene group.
  • R 4 is an alkylene group of up to 6 carbon atoms, most preferably methylene or ethylene.
  • Film-forming polymers of the invention with values of X'--Q defined above can be made from many known polymers, including, for example, polyacrylamide, poly(haloalkylacrylate), poly(acryloyl chloride), chloromethylpolystyrene, poly(hydroxyalkyl methacrylate), polysaccharide, poly(allyl alcohol), poly(N-methylol acrylamide), poly(alkylacrylate), poly(alkylmethacrylate) and poly(glycidyl methacrylate).
  • the side chains of these known polymers can be converted to X'--Q side chains of the present invention in various ways, as will be clear to those skilled in the art. For example:
  • the Mannich reaction can be used to quaternise the amido NH 2 group of polyacrylamide.
  • those polymers with a carboxyl ester group can be transesterified with, for example, a glycol and then treated as in (c). These procedures are merely examples.
  • the polymers of the invention can also, of course, be made from known polymers which have at least one quaternisable nitrogen atom present in a side chain.
  • known polymers include, for example, polyvinyl pyridine, polyvinyl imidazoline and polyvinyl imidazole.
  • Polymers of the invention include:
  • polymers of the invention are those which comprise units of formula II wherein X is selected from
  • R 4 contains from 1 to 6 carbon atoms and is most preferably methylene or ethylene.
  • m and p can each independently be zero. Normally, neither m nor p will be zero. When p is not zero, preferred units of formula III include those wherein Y is selected from
  • R 4 and R 5 will both contain from 1 to 6 carbon atoms, and most preferably R 4 is methylene or ethylene.
  • the quaternary nitrogen atoms have one long chain substituent i.e. one substituent having 8 or more, preferably 8 to 25, carbon atoms.
  • Any hydrocarbyl group having from 8 or more carbon atoms can be used.
  • the preferred such substituents are C 12 (dodecyl), C 16 (hexadecyl) and C 18 (stearyl) but other substituents may be employed, for example alkylaryl radicals.
  • the preferred R 1 and R 2 substituents are hydrocarbyl, eg. alkyl groups, having from 1 to 8 carbon atoms. Methyl groups are preferred, but they may themselves carry substituents as desired.
  • the possible substituents on the hydrocarbyl groups are halide, amino, nitro, hydroxyl or aryl, for example.
  • the quaternised nitrogen atoms may be attached directly to the polymeric backbone but usually instead are attached to a side chain extending from the backbone.
  • the side chain will preferably include some electron withdrawing atoms or groups.
  • the side chains can be formed from halocarboxylates, eg. haloacetates, by substituting the quaternised nitrogen at the halogen position.
  • halocarboxylates eg. haloacetates
  • Other halogenated side chains may also be employed to make the quaternised compounds, for example p-chloromethylphenyl units.
  • the side chain can also be a tertiary aromatic amine, for example 2-pyridyl or 4-pyridyl, or an aliphatic amine, for example dialkylaminoethyl ester and the quaternary formed by using haloalkyls.
  • a tertiary aromatic amine for example 2-pyridyl or 4-pyridyl
  • an aliphatic amine for example dialkylaminoethyl ester and the quaternary formed by using haloalkyls.
  • the side chain can be any alcohol or ester, the quaternary being added either by the use of base or Lewis acid catalysis of a ring opening addition by a quaternised epoxy or transesterification of a trialkyl oxy-ammonium halide catalysed by a transition metal catalyst.
  • carbon chain backbone of the polymer is not critical provided that it does not contain substituents antagonistic to the intended use of the polyquat.
  • One highly preferred material is polyvinyl alcohol to which side chains can be attached via the pendant OH groups.
  • Q is preferably selected from:
  • R 1 and R 2 are the same or different and are each a C 1 to C 8 substituted or unsubstituted hydrocarbyl group, R 3 is a C 8 to C 25 substituted or unsubstituted hydrocarbyl group, and Z - is an anion;
  • R 1 and R 2 are both alkyl groups.
  • R 3 is preferably a linear saturated hydrocarbyl group, preferably C 12 to C 18 .
  • Z - is preferably a halide ion, most preferably chlorine or bromine.
  • q is preferably 2,3 or 4.
  • the film-forming polymers used in the present invention can have a very high antiperspirant efficacy.
  • Efficacy was measured using a standard forearm sweat reduction test and the standard FDA axilla sweat reduction test (Federal Register Aug. 20th 1982 (162 FR 36492.) For example, we have found that a concentration as low as 3% by weight in an aqueous alcohol (30% water) dispersion can be more efficacious than a conventional 20% ACH solution.
  • the efficacy does vary among the polymers. In general, the efficacy increases with increasing chain length of the quaternary nitrogen substituents. Efficacy also tends to increase with increasing water-content of the compositions.
  • Quaternisation can be as low as 1%, but we prefer from about 25% up to 95% or more, and more preferably at least 75%, most especially at least 85%.
  • the quaternised polymeric materials can be made in a variety of ways as previously described, depending on their precise constitution. Usually, however, a polymeric material with a suitably reactive side chain is reacted with a tertiary amine.
  • poly(vinylchloroacetate) can be reacted with stearyldimethylamine to make the antiperspirant polyquat stearyldimethylamine quaternised poly(vinylchloroacetate).
  • the poly(vinylchloroacetate) can be made by reacting polyvinyl alcohol with chloroacetyl chloride. Those skilled in the art will know of these types of reactions and no further teaching in connection therewith will be given herein.
  • the antiperspirant efficacy of the polyquats is improved by the presence of water. It is preferred, therefore, to use them in formulations where water can be present. Accordingly, we prefer to use them in roll-ons, creams, gels and stick formulations, rather than in aerosols.
  • the molecular weights of the polymers of the invention can vary widely, but we prefer to use polymers in which (m+n+p) is from 20 to 2000 units, most preferably 200 to 1000 units. In the case of a 25% degree of substitution, 25% of the units in the polymer will be of formula I above. At very high degrees of substitution e.g. 95%, virtually all the polymer units are those of formula I.
  • the polymers can contain two or more different formula I groups in the same polymer, i.e. mixed polyquats. These polymers are usually made by using two different amines in the quaternisation procedure. They are especially useful in providing a bactericidal effect.
  • the polymers of the invention can be homopolymers or copolymers made from two or more monomers. It can be advantageous to use copolymers in order to provide more closely the qualities desired in the film-forming polymer.
  • poly(vinylalcohol) polymers can be made softer by copolymerising the vinyl alcohol with ethylene.
  • the units derived from the ethylene are formula III units in which Y is hydrogen.
  • a composition of the invention is mixed with other components of the formulation.
  • sticks can be formed from a soap gel, a wax, or a dibenzylidine sorbitol product. No detailed description thereof will be given.
  • the reaction was performed on poly(vinylalcohol) samples of molecular weight 9,000, 14,000, 22,000 and 49,000, with degrees of polymerisation (DP) of (approximately) 200, 300, 500 and 1100, respectively, and degrees of hydrolysis of 98.4%, 88% and 80%, respectively.
  • the degree of hydrolysis indicates the extent of conversion of polyvinylacetate to polyvinylalcohol.
  • the poly(vinylchloroacetate) was derived from 9000 molecular weight poly(vinylalcohol) as described in Example 1. This poly(vinylchloroacetate) (0.1 mol) was dissolved in ethyl acetate (150 ml). To this solution was added the required amount of stearyldimethylamine. This reaction was refluxed for three hours. The quaternised polymer precipitated out. The excess ethyl acetate was decanted off and the product was triturated with ethyl acetate, filtered and dried in a vacuum oven at room temperature. When an equimolar amount of SDMA was added, the substitution was about 88% by nitrogen analysis. Elemental analysis indicated 88% quaternisation.
  • the ratio of poly(vinylchloroacetate) to SDMA was varied as follows: 1:0.5, 1:0.4, 1:0.3, 1:0.2 and 1:0.1 to provide a number of products of varying quaternisation.
  • the same results were obtained when dimethylformamide was used as the solvent in place of ethyl acetate.
  • Example 2 was repeated but using dodecyldimethylamine instead of stearyl dimethylamine. Similar results were obtained.
  • the monoquaternary of N,N,N',N'-tetramethylethylenediamine (2 ⁇ 10 -4 mol) was added to a solution of poly(vinylchloroacetate) (0.01 mol) in dimethylformamide (100 ml) and stirred at 50° C. for 24 h.
  • the poly(vinylchloroacetate) was made from poly(vinylalcohol) of molecular weight 14000, approximate DP 300, by the method of Example 1.
  • Stearyl dimethylamine (1 ⁇ 10 -2 mol) was then added and heating and stirring continued for a further 48 h.
  • the precipitate which formed was triturated with ethyl acetate (twice) and dried to give a white powder. Yield 75%.
  • Poly(vinylalcohol-co-ethylene) was converted to the chloroacetate derivative by the process of Example 1.
  • the poly(vinylchloroacetate-co-ethylene) (0.04 mol, ethylene content 27 mol %) was dissolved in dimethylformamide (150 ml). Stearyl dimethyldiamine (0.035 mol) was added and the mixture stirred at 50° C. for 72 h. The solid precipitate which formed was triturated with fresh ethyl acetate (twice) and dried under vacuum to given an off-white powder. Yield 80%.
  • the poly(styrene-co-allyl chloroacetate) (0.04 mol. styrene content 94 mol %) was dissolved in ethyl acetate (150 ml). Stearyl dimethyldiamine (3 ⁇ 10 -3 mol) was added and the mixture stirred at 50° C. for 72 h. The solvent was removed under vacuum. The polymer was purified by repeated dissolution in dichloromethane and precipitation into an excess of cold diethyl ether. The polymer was dried under vacuum to give a pale yellow powder. Yield 75%.
  • An example of a stick product of the invention is:
  • An example of an aerosol of the invention is:

Abstract

Novel film-forming polymers having a carbon backbone and pendant groups containing quaternised nitrogen atoms, at least one substituent on the quaternised nitrogen being hydrophobic and containing at least 8 carbon atoms, have antiperspirant properties. For use as antiperspirants, they are dissolved or suspended in a non-aqueous carrier with a small amount of water.

Description

This is a continuation of pending application Ser. No. PCT/GB95/00800filed Apr. 6, 1995.
This is a continuation of pending application Ser. No. PCT/GB95/00800filed Apr. 6, 1995.
This invention relates to certain film-forming polymers and to their use as antiperspirants.
It has been known for many years to use basic aluminium chloride (ACH) as an antiperspirant material, and products containing it are commonly available for example as aerosols, sticks, roll-ons, gels and creams. Whilst ACH is a very effective antiperspirant, it has some drawbacks and there is concern generally as to the desirability of using aluminium-containing materials for this purpose.
WO 93/24105 describes topical antiperspirant compositions consisting essentially of an effective antiperspirant amount of a non-toxic water-insoluble occlusive film-forming polymer. Among the preferred polymers are alkyl olefinic acid amide/olefinic acid or ester copolymers, alone or in combination with a PVP-linear alpha-olefin copolymer or other water-repellent polymer. These compositions are said to function as antiperspirants by the formation of a water-insoluble occlusive film on the skin, which reduces under-arm perspiration. They are described for use with ACH or alone.
There have been many proposals in the past to apply film-forming polymers to the skin for various purposes. The achievement of good antiperspirancy in this way has, however, proved very difficult. Not only is the quality of antiperspirancy difficult to find, but it is also difficult to overcome the important problem of providing adequate substantivity of the polymer towards the skin so that it remains in place in use.
We have now devised some film-forming polymers which are novel per se and which can provide excellent substantivity when applied topically to the skin, and additionally provide good antiperspirancy.
According to one aspect of the present invention, there is provided a film-forming polymer comprising units of the formulae: ##STR1## wherein X is a group which can be directly quaternised by reaction with an amine, or itself comprises a quaternisable nitrogen atom;
X'--Q is quaternised X, where Q is the quaternised nitrogen group and X' may be non-existent;
Q has at least one quaternised nitrogen atom having at least one substituent thereon which is hydrophobic and contains at least 8 carbon atoms;
Y is any atom or group which cannot be directly quaternised and does not comprise a quaternisable nitrogen atom;
R is hydrogen or alkyl (the alkyl preferably being C1 to C6
m and p can each be 0 or an integer;
(n+m+p) is from 20 to 2000, preferably 20 to 1000;
n/(n+m+p) % is from 1% to 100% preferably 25% to 95%; and wherein the polymer can contain two or more different units of formula I, formula II and/or formula III.
These polymers are useful as antiperspirants, and the invention also includes an antiperspirant composition which comprises, as the main or only active antiperspirant ingredient, a film-forming polymer of the invention and a cosmetically acceptable non-aqueous carrier therefor which may be in admixture with a minor amount of water.
In the compositions of the invention, X is a group which either contains a quaternisable nitrogen atom, or which can be directly quaternised by reaction with an amine. The amine(s) can itself be in quaternised form if desired.
The compositions of the invention can contain a small amount (i.e. usually less than 5% by weight) of an aluminium antiperspirant, but in general the presence of aluminium antiperspirants reduces the efficacy of the compositions and we prefer the compositions to be substantially free from aluminium. The compositions can be formulated into aerosol, solid stick, roll-on, gel or cream formulations, for example.
European patent specification no. 0141269 describes certain polyvinyl alcohol polymers having oxylinked pendant quaternary ammonium or tertiary amine groups, as aids in reducing moisture loss when applied to skin as conditioning lotions or ointments in cosmetic and pharmaceutical formulations. In general, moisture loss polymers of this type function by forming a thin film on the surface of the skin. This film reduces transepidermal loss of moisture. However, this is a different effect from the antiperspirancy function of ACH. An antiperspirant functions to stop or significantly reduce the aqueous discharge from sweat ducts, and this is two or more orders of magnitude greater than transepidermal moisture loss. Thus, film-forming polymers known for use in reducing transepidermal loss cannot be expected simultaneously to provide any significant antiperspirant effect. In EP-A-0141269, the polyvinyl alcohol derivatives are used in amounts from 0.5-5% by weight of antiperspirant compositions containing conventional amounts of ACH, one example being 4% of the polymer in a composition containing 57% Al Zr tetrachloro-hydrex-Gly Rezol 36G (Reheis). This is quite different from the compositions of the present invention where amounts of ACH greater than about 5% tend to cause a reduction of antiperspirant efficacy.
Further, the polyvinyl alcohol polymers described in EP-A-0141269 are soluble or dispersible in water so that they will function to reduce transepidermal loss and be compatible with conventional aqueous-based cosmetic and personal care products. In contrast, the polymers used in the present invention are hardly soluble or dispersible in water at all, and require an alcoholic or other non-aqueous solvent carrier. Indeed, dispersions are unstable in the presence of significant amounts of water.
In the polymers of the invention, it is important that the quaternary nitrogen atoms have a hydrophobic substituent of relatively large size, i.e. at least C8. The effect of this hydrophobic substituent is to cause the polymer to change shape in the presence of any water which will be present during use of the polymer as an antiperspirant. It is believed that the change of shape is such as to express the ionic groups and this significantly improves the substantivity towards human skin. The polymers of the invention thus have good substantivity and also show a marked antiperspirant effect.
A preferred substituent for the quaternary nitrogen group is a substituted or unsubstituted hydrocarbyl group containing from 8 to 24 carbon atoms. Possible substituents include, for example, halogen, amino, nitrate, hydroxyl or aryl substituents. More preferably, the hydrocarbyl group is a linear saturated group, most preferably an alkyl group, especially of 12 to 18 carbon atoms, e.g. dodecyl or stearyl. It is to be understood that by "antiperspirant" we mean a substance which when applied to the skin as an antiperspirant reduces wetness by at least 20%. (Federal Register, Oct. 10th 1978 (43 FR 46694) and Federal Register, Aug. 20th 1982 (162 FR 36492).)
Conventionally, antiperspirants are usually formulated as roll-ons, sticks, aerosols, gels or creams. For the manufacture of these formulations, it is preferred in general that the active antiperspirant be in solution. Alternatively, a dispersion can be used provided it is relatively stable. Since the film-forming polymers used in the present invention are generally not soluble in water, they are dissolved or dispersed in a non-aqueous cosmetically acceptable carrier. The amount of film-forming polymer is generally from 1% to 20% by weight, preferably from 6% to 10% by weight. Examples of suitable carriers include alcohols such as ethanol, glycols such as propylene glycol, dipropylene glycol, butylene glycol, triols such as glycerol, propylene carbonate and volatile silicones including, for example, cyclic silicones, linear silicones and low molecular weight dimethicones. Some water can be included provided that the composition remains as a solution or is a stable dispersion. The addition of too much water will destabilise the dispersions. The amount of water which can be tolerated varies from polymer to polymer and with the non-aqueous carrier, and may be as little as 1% up to amounts of 30% or more. It will, however, always be less than the amount of non-aqueous carrier, i.e. it is present in minor amount relative thereto. In any particular case, routine trials will indicate the limits. It is preferred that, in the final formulation, some water be present.
In the case of dispersions of the invention, it is preferred that the disperse phase be from 5 to 10 micrometres in size.
The precise choice of film-forming polymer is not critical. Among the preferred polymers are those wherein, in the units of formula I, X' is an alkylene carbonyl oxy group (--R4.CO.O--) a carbonyl oxyalkylene group (--CO.O.R4 --), or an arylene (e.g. --C6 H4 --) or aralkylene (e.g. --C6 H4 --R4 --) group. Preferably, X' has the formula --O.CO.CH2 --(the oxygen being attached to the --CR-group) and R is hydrogen or methyl; or X' is a carbonyloxyethylene-oxyethylene group (the carbon being attached to the --CR-group) and R is methyl; or X' is a benzyl group (the benzyl --CH2 being attached to Q) and the R is hydrogen. These polymers can be variously derived from, for example, polyvinylalcohol, haloalkyl polystyrenes and polyhydroxyalkyl methacrylates. Halogens can be introduced into hydroxy side-chains using chloroacetate, and the halogen then quaternised.
Other preferred values for X' in the formula I units are:
--CO.O.R4 -- --O.CO.R4 --
--CO-- ##STR2## --CO.O.R4 --O.CO.R4 ----R4 --O.CO.R4 --
--CO.NH.CH2 O.COR4 --
--CO.O.R4.OR4.OCOR4 --
--CO.O.R4.O.R4 --
wherein each R4 is independently an alkylene group.
Preferably, R4 is an alkylene group of up to 6 carbon atoms, most preferably methylene or ethylene.
Film-forming polymers of the invention with values of X'--Q defined above can be made from many known polymers, including, for example, polyacrylamide, poly(haloalkylacrylate), poly(acryloyl chloride), chloromethylpolystyrene, poly(hydroxyalkyl methacrylate), polysaccharide, poly(allyl alcohol), poly(N-methylol acrylamide), poly(alkylacrylate), poly(alkylmethacrylate) and poly(glycidyl methacrylate). The side chains of these known polymers can be converted to X'--Q side chains of the present invention in various ways, as will be clear to those skilled in the art. For example:
(a) the Mannich reaction can be used to quaternise the amido NH2 group of polyacrylamide.
(b) those known polymers with halogen in the side chain can be quaternised directly by reaction with an amine.
(c) those polymers with a hydroxyl (or epoxide) group in the side chain can be converted to the chloroacetate (or an equivalent halocarboxylate) derivative which can then be quaternised.
(d) those polymers with a carboxyl ester group can be transesterified with, for example, a glycol and then treated as in (c). These procedures are merely examples.
The polymers of the invention can also, of course, be made from known polymers which have at least one quaternisable nitrogen atom present in a side chain. Such known polymers include, for example, polyvinyl pyridine, polyvinyl imidazoline and polyvinyl imidazole. Polymers of the invention include:
(i) those which contain formula I units of formula ##STR3## wherein R is hydrogen or an alkyl group, R6 is a single bond or an alkylene group, R3 is hydrophobic and contains at least 8 carbon atoms, and Z- is an anion.
(ii) those wherein, in the units of formula I, X'--Q is selected from ##STR4## wherein R6 is a single bond or an alkylene group, R3 is hydrophobic and contains at least 8 carbon atoms, and Z- is an anion.
Among the preferred polymers of the invention are those which comprise units of formula II wherein X is selected from
--Hal; --R4 Hal; --O.CO.R4.Hal
CO.O.R4.Hal; --CO.Hal; ##STR5## CO.NH.O.CO.R4 Hal; CO.O.R4.O.CO.R4.Hal; ##STR6## wherein R4 is an alkylene group, and Hal is a halogen. preferably chlorine or bromine.
Preferably, R4 contains from 1 to 6 carbon atoms and is most preferably methylene or ethylene.
In the polymers of the invention, m and p can each independently be zero. Normally, neither m nor p will be zero. When p is not zero, preferred units of formula III include those wherein Y is selected from
--H; --OH; --CONH2 ; --CO.O.R4.OH;
--R4 OH; --CONHR4 OH; ##STR7## --CO.O.R5 ; --CO.O.R4.O.R4.OH; wherein R4 is an alkylene group and R5 is an alkyl group.
Preferably, R4 and R5 will both contain from 1 to 6 carbon atoms, and most preferably R4 is methylene or ethylene.
In the quaternised polymers of the invention, the quaternary nitrogen atoms have one long chain substituent i.e. one substituent having 8 or more, preferably 8 to 25, carbon atoms. Any hydrocarbyl group having from 8 or more carbon atoms can be used. Among the preferred such substituents are C12 (dodecyl), C16 (hexadecyl) and C18 (stearyl) but other substituents may be employed, for example alkylaryl radicals. The preferred R1 and R2 substituents are hydrocarbyl, eg. alkyl groups, having from 1 to 8 carbon atoms. Methyl groups are preferred, but they may themselves carry substituents as desired. Among the possible substituents on the hydrocarbyl groups are halide, amino, nitro, hydroxyl or aryl, for example.
However, regardless of which particular values for the three substituents on the nitrogen are chosen, it is important that together they have a hydrophobicity to promote the substantivity of the polymer as previously described. The substantivity to skin can be impaired if the substituents are so bulky as to cause steric hindrance to the quaternary ammonium ion. Generally, two of the groups will be small relative to the main hydrophobic group of at least 8 carbon atoms.
The quaternised nitrogen atoms may be attached directly to the polymeric backbone but usually instead are attached to a side chain extending from the backbone. In order to promote the formation and stability of the quaternary ammonium groups, the side chain will preferably include some electron withdrawing atoms or groups. Thus, as described above, the side chains can be formed from halocarboxylates, eg. haloacetates, by substituting the quaternised nitrogen at the halogen position. Other halogenated side chains may also be employed to make the quaternised compounds, for example p-chloromethylphenyl units.
The side chain can also be a tertiary aromatic amine, for example 2-pyridyl or 4-pyridyl, or an aliphatic amine, for example dialkylaminoethyl ester and the quaternary formed by using haloalkyls.
The side chain can be any alcohol or ester, the quaternary being added either by the use of base or Lewis acid catalysis of a ring opening addition by a quaternised epoxy or transesterification of a trialkyl oxy-ammonium halide catalysed by a transition metal catalyst.
The nature of the carbon chain backbone of the polymer is not critical provided that it does not contain substituents antagonistic to the intended use of the polyquat. One highly preferred material is polyvinyl alcohol to which side chains can be attached via the pendant OH groups.
In the film-forming polymers of the invention, Q is preferably selected from:
(a) --N+ R1 R2 R3 Z, where R1 and R2 are the same or different and are each a C1 to C8 substituted or unsubstituted hydrocarbyl group, R3 is a C8 to C25 substituted or unsubstituted hydrocarbyl group, and Z- is an anion;
(b) ##STR8## where R3 and each Z- are independently as defined in (a) above;
(c) ##STR9## where R3 and each Z- are independently as defined in (a) above;
(d) ##STR10## where R3 is as defined in (a) above; (e) ##STR11## where R3 and each Z- are independently as defined in (a) above and q is from 2 to 10.
Preferably, R1 and R2 are both alkyl groups. R3 is preferably a linear saturated hydrocarbyl group, preferably C12 to C18. In the above formulae for Q, and in all occurrences in the specification and claims, Z- is preferably a halide ion, most preferably chlorine or bromine.
In the diquaternary (e) above, q is preferably 2,3 or 4.
The film-forming polymers used in the present invention can have a very high antiperspirant efficacy. (Efficacy was measured using a standard forearm sweat reduction test and the standard FDA axilla sweat reduction test (Federal Register Aug. 20th 1982 (162 FR 36492.) For example, we have found that a concentration as low as 3% by weight in an aqueous alcohol (30% water) dispersion can be more efficacious than a conventional 20% ACH solution. The efficacy does vary among the polymers. In general, the efficacy increases with increasing chain length of the quaternary nitrogen substituents. Efficacy also tends to increase with increasing water-content of the compositions.
In the quaternised polymers of the invention, it is not essential that every side chain (or group pendant from the main backbone chain) be quaternised. With increasing quaternisation, efficacy tends to rise but very useful and adequate antiperspirancy can be achieved with relatively low quaternisation. Quaternisation can be as low as 1%, but we prefer from about 25% up to 95% or more, and more preferably at least 75%, most especially at least 85%.
The quaternised polymeric materials can be made in a variety of ways as previously described, depending on their precise constitution. Usually, however, a polymeric material with a suitably reactive side chain is reacted with a tertiary amine. For example, poly(vinylchloroacetate) can be reacted with stearyldimethylamine to make the antiperspirant polyquat stearyldimethylamine quaternised poly(vinylchloroacetate). The poly(vinylchloroacetate) can be made by reacting polyvinyl alcohol with chloroacetyl chloride. Those skilled in the art will know of these types of reactions and no further teaching in connection therewith will be given herein.
As stated above, the antiperspirant efficacy of the polyquats is improved by the presence of water. It is preferred, therefore, to use them in formulations where water can be present. Accordingly, we prefer to use them in roll-ons, creams, gels and stick formulations, rather than in aerosols.
The molecular weights of the polymers of the invention can vary widely, but we prefer to use polymers in which (m+n+p) is from 20 to 2000 units, most preferably 200 to 1000 units. In the case of a 25% degree of substitution, 25% of the units in the polymer will be of formula I above. At very high degrees of substitution e.g. 95%, virtually all the polymer units are those of formula I.
The polymers can contain two or more different formula I groups in the same polymer, i.e. mixed polyquats. These polymers are usually made by using two different amines in the quaternisation procedure. They are especially useful in providing a bactericidal effect.
The polymers of the invention can be homopolymers or copolymers made from two or more monomers. It can be advantageous to use copolymers in order to provide more closely the qualities desired in the film-forming polymer. For example, poly(vinylalcohol) polymers can be made softer by copolymerising the vinyl alcohol with ethylene. In the resulting polymers of the invention, the units derived from the ethylene are formula III units in which Y is hydrogen.
In order to make a conventional antiperspirant formulation using the film-forming antiperspirant polymers of this invention, a composition of the invention is mixed with other components of the formulation. The various ways in which this is done will be clear to those skilled in the art. For example, sticks can be formed from a soap gel, a wax, or a dibenzylidine sorbitol product. No detailed description thereof will be given.
In order that the invention may be more fully understood, the following Examples are given by way of illustration only.
EXAMPLE 1 Preparation of chloroacetate derivatives of hydroxy polymers
To the appropriate hydroxy polymer (0.1 mol) were added chloroacetyl chloride (0.3 mol) and water (a few drops). The heterogeneous mixture obtained was stirred at room temperature under anhydrous conditions for 4 h. The viscous homogeneous mixture formed was diluted with ethyl acetate. The polymer was precipitated into an excess of ethanol, filtered and dried under vacuum to give a light brown powder. Yield 75%.
The reaction was performed on poly(vinylalcohol) samples of molecular weight 9,000, 14,000, 22,000 and 49,000, with degrees of polymerisation (DP) of (approximately) 200, 300, 500 and 1100, respectively, and degrees of hydrolysis of 98.4%, 88% and 80%, respectively. The degree of hydrolysis indicates the extent of conversion of polyvinylacetate to polyvinylalcohol.)
EXAMPLE 2 Quaternisation of poly(vinylchloroacetate) with stearyl dimethylamine (SDMA)
The SDMA quaternary was prepared by reacting poly(vinylchloroacetate) with stearyl dimethylamine: ##STR12## where n=x+y.
The poly(vinylchloroacetate) was derived from 9000 molecular weight poly(vinylalcohol) as described in Example 1. This poly(vinylchloroacetate) (0.1 mol) was dissolved in ethyl acetate (150 ml). To this solution was added the required amount of stearyldimethylamine. This reaction was refluxed for three hours. The quaternised polymer precipitated out. The excess ethyl acetate was decanted off and the product was triturated with ethyl acetate, filtered and dried in a vacuum oven at room temperature. When an equimolar amount of SDMA was added, the substitution was about 88% by nitrogen analysis. Elemental analysis indicated 88% quaternisation.
The ratio of poly(vinylchloroacetate) to SDMA was varied as follows: 1:0.5, 1:0.4, 1:0.3, 1:0.2 and 1:0.1 to provide a number of products of varying quaternisation. The same results were obtained when dimethylformamide was used as the solvent in place of ethyl acetate.
______________________________________
          Theory (w/w %)
                    Found (w/w %)
______________________________________
Carbon      69.0        64.5
Hydrogen    11.5        10.3
Nitrogen    3.4         3.0
______________________________________
EXAMPLE 3
Example 2 was repeated but using dodecyldimethylamine instead of stearyl dimethylamine. Similar results were obtained.
EXAMPLE 4
The efficacy of various solutions of the polyquats of Examples 2 and 3 was tested by routine methods and compared to conventional ACH solutions. The results showed that the stearyl quaternary was more efficacious than the dodecyl quaternary, and that efficacy increased with increasing degrees of quaternisation. In general, the efficacy was close to that of ACH. Substantivity to human skin was excellent. The results of the tests were as follows:
______________________________________
Forearm Efficacy of Polyquat Formulations
Formulation % w/w
                          Volatile
Polyvinyl-                Silicone      Efficacy
chloroacetate
        Polymer  Ethanol  VS 344 Water  %
______________________________________
SDMA
1:1     8        62       --     30     70.6
        5        65       --     30     64.0
        3.5      66.5     --     30     54.0
        2        68       --     30     17.5
        8        72       --     20     47.8
        8        82       --     10     39.2
        8        62       30     --     45.9
1:0.5   8        62       --     30     55.3
1:0.25  8        62       --     30     43.8
DDMA
1:1     8        62       --     30     56.6
1:0.25  8        62       --     30     16.8
______________________________________
 The polyvinylchloroacetate is derived from polyvinyl alcohol (DP 320)
______________________________________
Standard FDA Hot Room Efficacy Test
Formulation % w/w
Polyvinyl-                Volatile
chloroacetate             Silicone      Efficacy
SDMA    Polymer  Ethanol  VS 344 Water  %
______________________________________
1:1     8        62       --     30     28.4
______________________________________
 Polyvinylchloroacetate derived from polyvinylalcohol (88% hydrolysed
 DP200)
EXAMPLE 5 Quaternisation of the chloroacetate derivative of poly(2-hydroxyethyl methacrylate) with stearyl dimethylamine
The chloroacetate derivative of poly(2-hydroxyethyl methacrylate) (0.01 mol) was dissolved in dimethylformamide (100 ml). To the solution was added stearyl dimethyldiamine (0.012 mol) and this was left stirring at 60° C. for 72 h. The polymer was precipitated into an excess of ethyl acetate, triturated with fresh ethyl acetate (twice) and dried under vacuum to give a pale yellow powder. Yield 60%.
Elemental analysis indicated 40% quaternisation.
______________________________________
          Theory (w/w %)
                    Found (w/w %)
______________________________________
Carbon      64.8        61.2
Hydrogen    10.6        9.5
Nitrogen    5.4         2.2
______________________________________
EXAMPLE 6 Quaternisation of poly(4-vinylpyridine) with 1-bromohexadecane
To a viscous solution of poly(4-vinylpyridine), molecular weight 50000, approximate DP 475, (0.02 mol) in methanol (100 ml) was added 1-bromohexadecane (0.04 mol) and this was stirred under reflux for 5 days. The solvent was removed under vacuum. The polymer was purified by repeated dissolution in dichloromethane and precipitation into an excess of cold diethyl ether. The polymer was dried under vacuum to give a light-brown powder. Yield 85%. Halide analysis indicated 97% quaternisation. Analysis for bromine revealed 18.9% (19.5% expected).
EXAMPLE 7 Quaternisation of poly(vinylbenzylchloride) with stearyl dimethylamine
Poly(vinylbenzylchloride), molecular weight 55000, approximate DP 360, (2 g) and stearyl dimethylamine (3.9 g) were added to ethanol (25 ml) and heated under reflux with stirring for 24 h. The reaction mixture was precipitated into acetone (400 ml) and centrifuged. A white powder was recovered and dried under vacuum to constant weight (5 g). Elemental analysis indicated 90% quaternisation.
______________________________________
          Theory (w/w %)
                    Found (w/w %)
______________________________________
Carbon      77.4        71.8
Hydrogen    11.6        10.6
Chlorine    7.9         7.3
Nitrogen    3.1         2.7
______________________________________
EXAMPLE 8 Co-quaternisation of poly(vinylchloroacetate) with stearyl dimethylamine and 4,4'-dipyridyl N-benzyl bromide
Firstly, monoquaternisation of 4,4'-dipyridyl with benzyl bromide was effected as follows. Benzyl bromide (0.05 mol) was added dropwise to a solution of 4,4'-dipyridyl (0.065 mol) in dry acetone (100 ml) and the mixture was refluxed for 4 h. The solid formed was filtered and crystallised from diethyl ether:ethanol to give the pure product. Yield 60%.
______________________________________
          Theory (w/w %)
                    Found (w/w %)
______________________________________
Carbon      62.2        62.1
Hydrogen    4.9         4.7
Nitrogen    8.5         8.5
______________________________________
Then, the monoquaternary of 4,4'-dipyridyl (2×10-4 mol) was added to a solution of poly(vinylchloroacetate) (0.01 mol) in dimethylformamide (100 ml) and stirred at 50° C. for 24 h. (The poly(vinylchloroacetate) was made by the method of Example 1 from poly(vinylalcohol) of molecular weight 14000, approximate DP 300.) Stearyl dimethylamine (1×10-2 mol) was then added and heating and stirring continued for a further 48 h. The precipitate which formed was triturated with ethyl acetate (twice) and dried to give a white powder. Yield 75%.
EXAMPLE 9 Co-quaternisation of poly(vinylchloroacetate) with stearyl dimethylamine and N-octadecyl-N,N,N',N'-tetramethylethylenediamine bromide
Firstly, monoquaternisation of N,N,N',N'-tetramethylethylenediamine with 1-bromooctadecane was effected as follows. 1-bromooctadecane (0.03 mol) was added dropwise to a solution of N,N,N',N'-tetramethylethylenediamine (0.04 mol) in ethanol (200 ml). The mixture was refluxed for 24 h and the solvent removed under vacuum to give a waxy material. Yield 70%.
The monoquaternary of N,N,N',N'-tetramethylethylenediamine (2×10-4 mol) was added to a solution of poly(vinylchloroacetate) (0.01 mol) in dimethylformamide (100 ml) and stirred at 50° C. for 24 h. (The poly(vinylchloroacetate) was made from poly(vinylalcohol) of molecular weight 14000, approximate DP 300, by the method of Example 1.) Stearyl dimethylamine (1×10-2 mol) was then added and heating and stirring continued for a further 48 h. The precipitate which formed was triturated with ethyl acetate (twice) and dried to give a white powder. Yield 75%.
EXAMPLE 10 Quaternisation of poly(vinylalcohol-co-ethylene) with SDMA
Poly(vinylalcohol-co-ethylene) was converted to the chloroacetate derivative by the process of Example 1.
The poly(vinylchloroacetate-co-ethylene) (0.04 mol, ethylene content 27 mol %) was dissolved in dimethylformamide (150 ml). Stearyl dimethyldiamine (0.035 mol) was added and the mixture stirred at 50° C. for 72 h. The solid precipitate which formed was triturated with fresh ethyl acetate (twice) and dried under vacuum to given an off-white powder. Yield 80%.
EXAMPLE 11 Quaternisation of poly(styrene-co-allyl alcohol) with stearyl dimethylamine
Poly(styrene-co-allyl alcohol) molecular weight 1600, DP approximately 20, was converted to the chloroacetate derivative by the process of Example 1.
The poly(styrene-co-allyl chloroacetate) (0.04 mol. styrene content 94 mol %) was dissolved in ethyl acetate (150 ml). Stearyl dimethyldiamine (3×10-3 mol) was added and the mixture stirred at 50° C. for 72 h. The solvent was removed under vacuum. The polymer was purified by repeated dissolution in dichloromethane and precipitation into an excess of cold diethyl ether. The polymer was dried under vacuum to give a pale yellow powder. Yield 75%.
EXAMPLE 12
An example of a roll-on of the invention is:
______________________________________
                 %
______________________________________
Polyquat (Example 2)
                   8.0
Triclosan          0.3
Water              1.0
Cyclomethicone DC344
                   30.0
Ethanol            60.7
______________________________________
EXAMPLE 13
An example of a stick product of the invention is:
______________________________________
                %
______________________________________
Polyquat (Example 2)
                  8.00
Ethanol           53.95
Water             16.45
Stearyl alcohol   14.00
Castor oil        3.00
Talc              2.20
Silica            1.40
PEG               1.00
______________________________________
EXAMPLE 14
An example of an aerosol of the invention is:
______________________________________
                   %
______________________________________
Polyvinylchloroacetate/DMA (1:1)
                     4
Ethanol              74.5
Triethyl citrate     1.5
CAP 30               20
______________________________________

Claims (84)

We claim:
1. A topical composition for application to the skin comprising 1% to 20% by weight of a film-forming polymer dissolved in a cosmetically acceptable non-aqueous solvent carrier, wherein said film-forming polymer comprises units of the formula: ##STR13## wherein X is a group which can be directly quaternised by reaction with an amine, or itself comprises a quaternisable nitrogen atom;
X'--Q is quaternised X, where Q is the quaternised nitrogen group and X' may be non-existent;
Q has at least one quaternised nitrogen atom having at least one substituent thereon which is hydrophobic and contains at least 8 carbon atoms;
Y is any atom or group which cannot be directly quaternised and does not itself comprise a quaternisable nitrogen atom;
R is hydrogen or alkyl;
m and p can independently be 0 or an integer;
(n+m+p) is from 20 to 2000;
n/(n+m+p) % is from 25% to 95%;
and wherein the polymer may optionally contain two or more different units of formula I, formula II and/or formula III.
2. The topical composition of claim 1 wherein X'--Q is selected from ##STR14## wherein each R4 is independently an alkylene group of 1 to 6 carbon atoms and Q is selected from ##STR15## where R1 and R2 are the same or different and are each a C1 to C8 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, q is an integer from 2 to 10, and Z- is an anion.
3. The topical composition of claim 1 wherein X'--Q is selected from ##STR16## wherein R6 is a single bond or an alkylene group of 1 to 6 carbon atoms, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, and Z- is an anion.
4. The topical composition of claim 2 or 3 wherein
X is selected from --Hal, --R4 --Hal, --O--CO--R4 --Hal, --CO--O--R4 --Hal, --CO--Hal, --C6 H4 --R4 --Hal, --CO--O--R4 --O--R4 --Hal, --CO--NH--O--CO--R4 --Hal, --CO--O--R4 --O--CO--R4 --Hal; ##STR17## and Y is selected from --H, --OH, --CONH2, --CO--O--R4 --OH, --R4 --OH, --CO--NH--R4 --OH, --C6 H5, --C6 H4 --R5, --CO--O--R5, and --CO--O--R4 --O--R4 --OH;
wherein R4 is an alkylene group of 1 to 6 carbon atoms, R5 is an alkyl group of 1 to 6 carbon atoms and Hal is a halogen.
5. The topical composition of claim 4 wherein R is H or methyl, R1 and R2 are alkyl, R4 is methylene or ethylene, and Z- is halide.
6. The topical composition of claim 5 wherein R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms.
7. The topical composition of claim 4 wherein m and p are both integers.
8. The topical composition of claim 7 wherein n+m+p is from 200 to 1000.
9. The topical composition of claim 8 wherein R is H and Y is H.
10. The topical composition of claim 2 wherein X'--Q is --O--CO--CH2 --Q and X is --O--CO--CH2 --Cl.
11. The topical composition of claim 10 wherein R is H or methyl and Y is H or OH.
12. The topical composition of claim 11 wherein Q is --N+ R1 R2 R3 Z-.
13. The topical composition of claim 12 wherein R1 and R2 are alkyl, R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms, and Z- is halide.
14. The topical composition of claim 13 wherein m and p are both integers.
15. The topical composition of claim 14 wherein R is H and Y is H.
16. The topical composition of claim 2 wherein X'--Q is --C6 H4 --CH2 --Q and X is --C6 H4 --CH2 --Cl.
17. The topical composition of claim 16 wherein R is H or methyl, Y is H or OH, and Q is --N+ R1 R2 R3 Z-.
18. The topical composition of claim 3 wherein X'--Q is ##STR18## and X is ##STR19## wherein R is H and Z- is halide.
19. The topical composition of claim 4 wherein the non-aqueous solvent carrier comprises ethanol, propylene glycol, butylene glycol, dipropylene glycol, glycerol, propylene carbonate, volatile silicone, or a mixture of two or more of these.
20. The topical composition of claim 19 wherein the non-aqueous solvent carrier comprises ethanol and volatile silicone.
21. The topical composition of claim 19 wherein the non-aqueous solvent carrier additionally comprises up to 30% water, wherein the amount of water is sufficiently low to maintain the composition as a clear solution or stable dispersion.
22. A method of controlling perspiration which comprises applying to an area of skin which perspires a composition comprising 1% to 20% by weight of a film-forming polymer dissolved in a cosmetically acceptable non-aqueous solvent carrier, wherein said film-forming polymer comprises units of the formula: ##STR20## wherein X is a group which can be directly quaternised by reaction with an amine, or itself comprises a quaternisable nitrogen atom;
X'--Q is quaternised X, where Q is the quaternised nitrogen group and X' may be non-existent;
Q has at least one quaternised nitrogen atom having at least one substituent thereon which is hydrophobic and contains at least 8 carbon atoms;
Y is any atom or group which cannot be directly quaternised and does not itself comprise a quaternisable nitrogen atom;
R is hydrogen or alkyl;
m and p can independently be 0 or an integer;
(n+m+p) is from 20 to 2000;
n/(n+m+p) % is from 25% to 95%;
and wherein the polymer may optionally contain two or more different units of formula I, formula II and/or formula III.
23. The method of claim 22 wherein X'--Q is selected from ##STR21## wherein each R4 is independently an alkylene group of 1 to 6 carbon atoms and Q is selected from ##STR22## where R1 and R2 are the same or different and are each a C1 to C8 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, q is an integer from 2 to 10, and Z- is an anion.
24. The method of claim 22 wherein X'--Q is selected from ##STR23## wherein R6 is a single bond or an alkylene group of 1 to 6 carbon atoms, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, and Z- is an anion.
25. The method of claim 23 or 24 wherein
X is selected from --Hal, --R4 --Hal, --O--CO--R4 --Hal, --CO--O--R4 --Hal, --CO--Hal, --C6 H4 --R4 --Hal, --CO--O--R4 --O--R4 --Hal, --CO--NH--O--CO--R4 --Hal, --CO--O--R4 --O--CO--R4 --Hal; ##STR24## and Y is selected from --H, --OH, --CONH2, --CO--O--R4 --OH, --R4 --OH, --CO--NH--R4 --OH, --C6 H5, --C6 H4 --R5, --CO--O--R5, and --CO--O--R4 --O--R4 --OH;
wherein R4 is an alkylene group of 1 to 6 carbon atoms, R5 is an alkyl group of 1 to 6 carbon atoms and Hal is a halogen.
26. The method of claim 25 wherein R is H or methyl, R1 and R2 are alkyl, R4 is methylene or ethylene, and Z- is halide.
27. The method of claim 26 wherein R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms.
28. The method of claim 25 wherein m and p are both integers.
29. The method of claim 28 wherein n+m+p is from 200 to 1000.
30. The method of claim 29 wherein R is H and Y is H.
31. The method of claim 23 wherein X'--Q is --O--CO--CH2 --Q and X is --O--CO--CH2 --Cl.
32. The method of claim 31 wherein R is H or methyl and Y is H or OH.
33. The method of claim 32 wherein Q is --N+ R1 R2 R3 Z-.
34. The method of claim 33 wherein R1 and R2 are alkyl, R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms, and Z- is halide.
35. The method of claim 34 wherein m and p are both integers.
36. The method of claim 35 wherein R is H and Y is H.
37. The method of claim 23 wherein X'--Q is --C6 H4 --CH2 --Q and X is --C6 H4 --CH2 --Cl.
38. The method of claim 37 wherein R is H or methyl, Y is H or OH, and Q is --N+ R1 R2 R3 Z-.
39. The method of claim 24 wherein X'--Q is ##STR25## and X is ##STR26## wherein R is H and Z- is halide.
40. The method of claim 25 wherein the non-aqueous solvent carrier comprises ethanol, propylene glycol, butylene glycol, dipropylene glycol, glycerol, propylene carbonate, volatile silicone, or a mixture of two or more of these.
41. The method of claim 40 wherein the non-aqueous solvent carrier comprises ethanol and volatile silicone.
42. The method of claim 41 wherein the non-aqueous solvent carrier additionally comprises up to 30% water, wherein the amount of water is sufficiently low to maintain the composition as a clear solution or stable dispersion.
43. A topical composition for application to the skin comprising 1% to 20% by weight of a film-forming polymer dissolved in a cosmetically acceptable non-aqueous solvent carrier, wherein said film-forming polymer comprises units of the formula: ##STR27## wherein X is a group which can be directly quaternised by reaction with an amine, or itself comprises a quaternisable nitrogen atom;
X'--Q is quaternised X, where Q is the quaternised nitrogen group and X' may be non-existent;
Q has at least one quaternised nitrogen atom having at least one substituent thereon which is hydrophobic and contains at least 8 carbon atoms;
Y is any atom or group which cannot be directly quaternised and does not itself comprise a quaternisable nitrogen atom;
R is hydrogen or alkyl;
m and p are both integers;
(n+m+p) is from 20 to 2000;
n/(n+m+p) % is 1% or more;
and wherein the polymer may optionally contain two or more different units of formula I, formula II and/or formula III.
44. The topical composition of claim 43 wherein X'--Q is selected from ##STR28## wherein each R4 is independently an alkylene group of 1 to 6 carbon atoms and Q is selected from ##STR29## where R1 and R2 are the same or different and are each a C1 to C8 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, q is an integer from 2 to 10, and Z- is an anion.
45. The topical composition of claim 43 wherein X'--Q is selected from ##STR30## wherein R6 is a single bond or an alkylene group of 1 to 6 carbon atoms, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, and Z- is an anion.
46. The topical composition of claim 44 or 45 wherein
X is selected from --Hal, --R4 --Hal, --O--CO--R4 --Hal, --CO--O--R4 --Hal, --CO--Hal, --C6 H4 --R4 --Hal, --CO--O--R4 --O--R4 --Hal, --CO--NH--O--CO--R4 --Hal, --CO--O--R4 --O--CO--R4 --Hal; ##STR31## and Y is selected from --H, --OH, --CONH2, --CO--O--R4 --OH, --R4 --OH, --CO--NH--R4 --OH, --C6 H5, --C6 H4 --R5, --CO--O--R5, and --CO--O--R4 --O--R4 --OH;
wherein R4 is an alkylene group of 1 to 6 carbon atoms, R5 is an alkyl group of 1 to 6 carbon atoms and Hal is a halogen.
47. The topical composition of claim 46 wherein R is H or methyl, R1 and R2 are alkyl, R4 is methylene or ethylene, and Z- is halide.
48. The topical composition of claim 47 wherein R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms.
49. The topical composition of claim 46 wherein n/(n+m+p) % is from 25% to 95%.
50. The topical composition of claim 49 wherein n+m+p is from 200 to 1000.
51. The topical composition of claim 50 wherein R is H and Y is H.
52. The topical composition of claim 44 wherein X'--Q is --O--CO--CH2 --Q and X is --O--CO--CH2 --Cl.
53. The topical composition of claim 52 wherein R is H or methyl and Y is H or OH.
54. The topical composition of claim 53 wherein Q is --N+ R1 R2 R3 Z-.
55. The topical composition of claim 54 wherein R1 and R2 are alkyl, R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms, and Z- is halide.
56. The topical composition of claim 55 wherein R is H and Y is H.
57. The topical composition of claim 56 wherein n/(n+m+p) % is from 25% to 95%.
58. The topical composition of claim 44 wherein X'--Q is --C6 H4 --CH2 --Q and X is --C6 H4 --CH2 --Cl.
59. The topical composition of claim 58 wherein R is H or methyl, Y is H or OH, and Q is --N+ R1 R2 R3 Z-.
60. The topical composition of claim 45 wherein X'--Q is ##STR32## and X is ##STR33## wherein R is H and Z- is halide.
61. The topical composition of claim 46 wherein the non-aqueous solvent carrier comprises ethanol, propylene glycol, butylene glycol, dipropylene glycol, glycerol, propylene carbonate, volatile silicone, or a mixture of two or more of these.
62. The topical composition of claim 61 wherein the non-aqueous solvent carrier comprises ethanol and volatile silicone.
63. The topical composition of claim 61 wherein the non-aqueous solvent carrier additionally comprises up to 30% water, wherein the amount of water is sufficiently low to maintain the composition as a clear solution or stable dispersion.
64. A method of controlling perspiration which comprises applying to an area of skin which perspires a composition comprising 1% to 20% by weight of a film-forming polymer dissolved in a cosmetically acceptable non-aqueous solvent carrier, wherein said film-forming polymer comprises units of the formula: ##STR34## wherein X is a group which can be directly quaternised by reaction with an amine, or itself comprises a quaternisable nitrogen atom;
X'--Q is quaternised X, where Q is the quaternised nitrogen group and X' may be non-existent;
Q has at least one quaternised nitrogen atom having at least one substituent thereon which is hydrophobic and contains at least 8 carbon atoms;
Y is any atom or group which cannot be directly quaternised and does not itself comprise a quaternisable nitrogen atom;
R is hydrogen or alkyl;
m and p are both integers;
(n+m+p) is from 20 to 2000;
n/(n+m+p) % is 1% or more;
and wherein the polymer may optionally contain two or more different units of formula I, formula II and/or formula III.
65. The method of claim 64 wherein X'--Q is selected from ##STR35## wherein each R4 is independently an alkylene group of 1 to 6 carbon atoms and Q is selected from ##STR36## where R1 and R2 are the same or different and are each a C1 to C8 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, q is an integer from 2 to 10, and Z- is an anion.
66. The method of claim 64 wherein X'--Q is selected from ##STR37## wherein R6 is a single bond or an alkylene group of 1 to 6 carbon atoms, R3 is a C8 to C25 hydrocarbyl group unsubstituted or substituted with at least one halo, amino, nitro, hydroxyl or aryl group, and Z- is an anion.
67. The method of claim 65 or 66 wherein
X is selected from --Hal, --R4 --Hal, --O--CO--R4 --Hal, --CO--O--R4 --Hal, --CO--Hal, --C6 H4 --R4 --Hal, --CO--O--R4 --O--R4 --Hal, --CO--NH--O--CO--R4 --Hal, --CO--O--R4 --O--CO--R4 --Hal; ##STR38## and Y is selected from --H, --OH, --CONH2, --CO--O--R4 --OH, --R4 --OH, --CO--NH--R4 --OH, --C6 H5, --C6 H4 --R5, --CO--O--R5, and --CO--O--R4 --O--R4 --OH;
wherein R4 is an alkylene group of 1 to 6 carbon atoms, R5 is an alkyl group of 1 to 6 carbon atoms and Hal is a halogen.
68. The method of claim 67 wherein R is H or methyl, R1 and R2 are alkyl, R4 is methylene or ethylene, and Z- is halide.
69. The method of claim 68 wherein R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms.
70. The method of claim 67 wherein n/(n+m+p) % is from 25% to 95%.
71. The method of claim 70 wherein n+m+p is from 200 to 1000.
72. The method of claim 71 wherein R is H and Y is H.
73. The method of claim 65 wherein X'--Q is --O--CO--CH2 --Q and X is --O--CO--CH2 --Cl.
74. The method of claim 73 wherein R is H or methyl and Y is H or OH.
75. The method of claim 74 wherein Q is --N+ R1 R2 R3 Z-.
76. The method of claim 75 wherein R1 and R2 are alkyl, R3 is a linear saturated hydrocarbyl group of 12 to 18 carbon atoms, and Z- is halide.
77. The method of claim 76 wherein R is H and Y is H.
78. The method of claim 77 wherein n/(n+m+p) % is from 25% to 95%.
79. The method of claim 65 wherein X'--Q is --C6 H4 --CH2 --Q and X is --C6 H4 --CH2 --Cl.
80. The method of claim 79 wherein R is H or methyl, Y is H or OH, and Q is --N+ R1 R2 R3 Z-.
81. The method of claim 66 wherein X'--Q is ##STR39## and X is ##STR40## wherein R is H and Z- is halide.
82. The method of claim 67 wherein the non-aqueous solvent carrier comprises ethanol, propylene glycol, butylene glycol, dipropylene glycol, glycerol, propylene carbonate, volatile silicone, or a mixture of two or more of these.
83. The method of claim 82 wherein the non-aqueous solvent carrier comprises ethanol and volatile silicone.
84. The method of claim 82 wherein the non-aqueous solvent carrier additionally comprises up to 30% water, wherein the amount of water is sufficiently low to maintain the composition as a clear solution or stable dispersion.
US08/722,591 1994-04-07 1996-09-27 Film forming antiperspirant polymers Expired - Lifetime US5869600A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB9406854A GB9406854D0 (en) 1994-04-07 1994-04-07 Antiperspirants
AU21448/95A AU2144895A (en) 1994-04-07 1995-04-06 Film forming antiperspirant polymers
CA 2186594 CA2186594C (en) 1994-04-07 1995-04-06 Film forming antiperspirant polymers
BR9507302A BR9507302A (en) 1994-04-07 1995-04-06 Film-forming polymer antiperspirant composition and use as an antiperspirant of a solution or dispersion of a film-forming polymer
PCT/GB1995/000800 WO1995027473A1 (en) 1994-04-07 1995-04-06 Film forming antiperspirant polymers
CN95192934A CN1147763A (en) 1994-04-07 1995-04-06 Film forming antiperspirant polymers
US08/722,591 US5869600A (en) 1994-04-07 1996-09-27 Film forming antiperspirant polymers
US09/144,864 US5948882A (en) 1995-04-06 1998-09-01 Film forming antiperspirant polymers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406854A GB9406854D0 (en) 1994-04-07 1994-04-07 Antiperspirants
US08/722,591 US5869600A (en) 1994-04-07 1996-09-27 Film forming antiperspirant polymers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/144,864 Division US5948882A (en) 1995-04-06 1998-09-01 Film forming antiperspirant polymers

Publications (1)

Publication Number Publication Date
US5869600A true US5869600A (en) 1999-02-09

Family

ID=26304651

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/722,591 Expired - Lifetime US5869600A (en) 1994-04-07 1996-09-27 Film forming antiperspirant polymers

Country Status (7)

Country Link
US (1) US5869600A (en)
CN (1) CN1147763A (en)
AU (1) AU2144895A (en)
BR (1) BR9507302A (en)
CA (1) CA2186594C (en)
GB (1) GB9406854D0 (en)
WO (1) WO1995027473A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274127B1 (en) 2000-01-27 2001-08-14 The Procter & Gamble Company Anhydrous antiperspirant compositions containing water-reactive monomers as antiperspirant active
US6387356B1 (en) 2000-01-27 2002-05-14 Colgate-Palmolive Company Cosmetic composition
US20050112073A1 (en) * 2003-11-21 2005-05-26 The Procter & Gamble Company Antiperspirant methods and compositions
EP1928234A1 (en) * 2005-08-22 2008-06-11 Quick-Med Technologies, Inc. Disinfectant with quaternary ammonium polymers and copolymers
US20090117164A1 (en) * 2005-08-22 2009-05-07 Quick-Med Technologies, Inc. Disinfectant with Durable Activity Based on Alcohol-Soluble Quaternary Ammonium Polymers and Copolymers
FR2954150A1 (en) * 2009-12-17 2011-06-24 Oreal USE OF ONE OR MORE PRESSURE-SENSITIVE ADHESIVE COMPOUNDS AS AN AGENT FOR THE TREATMENT OF HUMAN PERSPIRATION
FR2954151A1 (en) * 2009-12-17 2011-06-24 Oreal USE OF A COSMETIC COMPOSITION COMPRISING AT LEAST ONE FILMOGENEOUS ELASTOMERIC POLYMER FOR THE TREATMENT OF HUMAN TRANSPIRATION
WO2011130455A1 (en) 2010-04-13 2011-10-20 Najib Babul Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
FR2976484A1 (en) * 2011-06-20 2012-12-21 Oreal Use of water dispersible or water soluble flocculant polymer comprising in side chain of non-quaternized pyridines groups connected directly or indirectly to the main chain, as an antiperspirant active ingredient
AU2009204189B2 (en) * 2008-01-08 2014-01-16 Quick-Med Technologies, Inc. Disinfectant alcohol-soluble quaternary ammonium polymers
WO2012175330A3 (en) * 2011-06-20 2014-11-27 L'oreal Cosmetic use of a flocculant polymer as antiperspirant
US9072747B2 (en) 2013-03-10 2015-07-07 Peritech Pharma Ltd. Topical compositions and methods of treatment of anorectal disorders
CN115505118A (en) * 2022-09-23 2022-12-23 浙江大学 Preparation method and application of quick-response ionized polyphenyl ether electrochromic compound film

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833964A (en) * 1996-03-20 1998-11-10 Colgate-Palmolive Company Antiperspirant stick composition
GB0031264D0 (en) 2000-12-21 2001-01-31 Unilever Plc Antiperspirant products
EP1443058A1 (en) 2003-01-29 2004-08-04 Firmenich Sa Polymeric particles and fragrance delivery systems
FR2972350B1 (en) * 2011-03-09 2013-09-27 Oreal PROCESS FOR TREATING TRANSPIRATION USING ENCAPSULATED SILICONE COMPOUNDS; COMPOSITIONS CONTAINING THEM
FR2973244B1 (en) 2011-03-31 2014-01-24 Oreal A METHOD COMPRISING THE APPLICATION OF ANTI-TRANSPIRANT MATERIAL CONTAINING AT LEAST TWO ZONES OF DIFFERENT POLYMERS
WO2012130690A2 (en) 2011-03-31 2012-10-04 L'oreal Process for treating human perspiration using a tautening hydrophobic film-forming polymer; compositions
FR2976486B1 (en) * 2011-06-20 2013-10-11 Oreal USE AS ANTI-TRANSPARENT AGENT OF A POLYURETHANE CATIONIC FLOCCULANT POLYMER
EP3639895A1 (en) 2018-10-18 2020-04-22 Unilever PLC Method of reducing perspiration

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966902A (en) * 1972-05-12 1976-06-29 Airwick Industries, Inc. Polymer complex carriers for an active ingredient
US4010252A (en) * 1974-12-19 1977-03-01 Colgate-Palmolive Company Antimicrobial compositions
GB1485373A (en) * 1973-11-08 1977-09-08 Unilever Nv Antiperspirant composition
US4057533A (en) * 1972-07-03 1977-11-08 Gaf Corporation Process for preparation of quaternized cationic vinyllactam-acrylamide copolymers
GB1572259A (en) * 1978-04-26 1980-07-30 Beecham Group Ltd Clavulanic acid derivatives
EP0141269A2 (en) * 1983-10-07 1985-05-15 Ici Americas Inc. Modified polyvinyl alcohol polymers
EP0162388A1 (en) * 1984-05-11 1985-11-27 Bristol-Myers Company Novel bile sequestrant resin and uses
EP0300490A2 (en) * 1987-07-23 1989-01-25 E.I. Du Pont De Nemours And Company Dry blending process for the quaternization of polyvinyl alcohol
US4883608A (en) * 1987-11-18 1989-11-28 Southwest Research Institute Polymeric decontamination composition
US5112886A (en) * 1986-09-26 1992-05-12 Ici Americas Inc. Allantoin salts of quaternary nitrogen containing polymers for use in skin conditioning, cosmetic and pharmaceutical formulations
US5209922A (en) * 1992-03-19 1993-05-11 Isp Investments Inc. Water soluble polymers having antifungal properties
EP0550969A2 (en) * 1992-01-08 1993-07-14 Mitsubishi Denki Kabushiki Kaisha IC card connector supporting/fixing mechanism
US5508024A (en) * 1992-05-22 1996-04-16 International Research And Development Corp. Topical antiperspirant composition consisting essentially of non-toxic water-insoluble occlusive film-forming antiperspirant polymer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01216916A (en) * 1988-02-25 1989-08-30 Daicel Chem Ind Ltd Method for preventing armpit odor

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966902A (en) * 1972-05-12 1976-06-29 Airwick Industries, Inc. Polymer complex carriers for an active ingredient
US4057533A (en) * 1972-07-03 1977-11-08 Gaf Corporation Process for preparation of quaternized cationic vinyllactam-acrylamide copolymers
GB1485373A (en) * 1973-11-08 1977-09-08 Unilever Nv Antiperspirant composition
US4010252A (en) * 1974-12-19 1977-03-01 Colgate-Palmolive Company Antimicrobial compositions
GB1572259A (en) * 1978-04-26 1980-07-30 Beecham Group Ltd Clavulanic acid derivatives
EP0141269A2 (en) * 1983-10-07 1985-05-15 Ici Americas Inc. Modified polyvinyl alcohol polymers
EP0162388A1 (en) * 1984-05-11 1985-11-27 Bristol-Myers Company Novel bile sequestrant resin and uses
US5112886A (en) * 1986-09-26 1992-05-12 Ici Americas Inc. Allantoin salts of quaternary nitrogen containing polymers for use in skin conditioning, cosmetic and pharmaceutical formulations
EP0300490A2 (en) * 1987-07-23 1989-01-25 E.I. Du Pont De Nemours And Company Dry blending process for the quaternization of polyvinyl alcohol
US4883608A (en) * 1987-11-18 1989-11-28 Southwest Research Institute Polymeric decontamination composition
EP0550969A2 (en) * 1992-01-08 1993-07-14 Mitsubishi Denki Kabushiki Kaisha IC card connector supporting/fixing mechanism
US5209922A (en) * 1992-03-19 1993-05-11 Isp Investments Inc. Water soluble polymers having antifungal properties
US5508024A (en) * 1992-05-22 1996-04-16 International Research And Development Corp. Topical antiperspirant composition consisting essentially of non-toxic water-insoluble occlusive film-forming antiperspirant polymer

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274127B1 (en) 2000-01-27 2001-08-14 The Procter & Gamble Company Anhydrous antiperspirant compositions containing water-reactive monomers as antiperspirant active
US6387356B1 (en) 2000-01-27 2002-05-14 Colgate-Palmolive Company Cosmetic composition
US20050112073A1 (en) * 2003-11-21 2005-05-26 The Procter & Gamble Company Antiperspirant methods and compositions
US7404946B2 (en) 2003-11-21 2008-07-29 The Procter And Gamble Company Antiperspirant methods and compositions
EP1928234A1 (en) * 2005-08-22 2008-06-11 Quick-Med Technologies, Inc. Disinfectant with quaternary ammonium polymers and copolymers
US20090117164A1 (en) * 2005-08-22 2009-05-07 Quick-Med Technologies, Inc. Disinfectant with Durable Activity Based on Alcohol-Soluble Quaternary Ammonium Polymers and Copolymers
US8343523B2 (en) 2005-08-22 2013-01-01 Quick-Med Technologies, Inc. Disinfectant with durable activity based on alcohol-soluble quaternary ammonium polymers and copolymers
EP1928234A4 (en) * 2005-08-22 2012-08-29 Quick Med Technologies Inc Disinfectant with quaternary ammonium polymers and copolymers
AU2009204189B2 (en) * 2008-01-08 2014-01-16 Quick-Med Technologies, Inc. Disinfectant alcohol-soluble quaternary ammonium polymers
WO2011073345A3 (en) * 2009-12-17 2012-05-03 L'oreal Use of one or more pressure-sensitive adhesive compounds as agent for the treatment of sweating in humans
WO2011073356A3 (en) * 2009-12-17 2011-08-11 L'oreal Use of a cosmetic composition comprising at least one film-forming elastomeric polymer for treating human perspiration.
FR2954151A1 (en) * 2009-12-17 2011-06-24 Oreal USE OF A COSMETIC COMPOSITION COMPRISING AT LEAST ONE FILMOGENEOUS ELASTOMERIC POLYMER FOR THE TREATMENT OF HUMAN TRANSPIRATION
FR2954150A1 (en) * 2009-12-17 2011-06-24 Oreal USE OF ONE OR MORE PRESSURE-SENSITIVE ADHESIVE COMPOUNDS AS AN AGENT FOR THE TREATMENT OF HUMAN PERSPIRATION
WO2011130455A1 (en) 2010-04-13 2011-10-20 Najib Babul Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
US11607407B2 (en) 2010-04-13 2023-03-21 Relmada Therapeutics, Inc. Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use
FR2976484A1 (en) * 2011-06-20 2012-12-21 Oreal Use of water dispersible or water soluble flocculant polymer comprising in side chain of non-quaternized pyridines groups connected directly or indirectly to the main chain, as an antiperspirant active ingredient
WO2012175330A3 (en) * 2011-06-20 2014-11-27 L'oreal Cosmetic use of a flocculant polymer as antiperspirant
US9072747B2 (en) 2013-03-10 2015-07-07 Peritech Pharma Ltd. Topical compositions and methods of treatment of anorectal disorders
US10085995B2 (en) 2013-03-10 2018-10-02 Peritech Pharma Ltd. Topical compositions and methods of treatment of anorectal disorders
US10085994B2 (en) 2013-03-10 2018-10-02 Peritech Pharma Ltd. Topical compositions and methods of treatment of topical disorders
CN115505118A (en) * 2022-09-23 2022-12-23 浙江大学 Preparation method and application of quick-response ionized polyphenyl ether electrochromic compound film
CN115505118B (en) * 2022-09-23 2024-02-09 浙江大学 Preparation method and application of quick-response ionized polyphenyl ether electrochromic compound film

Also Published As

Publication number Publication date
CA2186594A1 (en) 1995-10-19
BR9507302A (en) 1997-09-30
GB9406854D0 (en) 1994-06-01
CA2186594C (en) 2001-06-05
CN1147763A (en) 1997-04-16
AU2144895A (en) 1995-10-30
WO1995027473A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
US5869600A (en) Film forming antiperspirant polymers
US4837005A (en) Partially hydrolyzed, poly(N-acyl)alkylenimines in personal care
US6231876B1 (en) Use of water-soluble copolymers as active ingredients in cosmetics
US4606916A (en) Quaternary oxalkylated polyesters, a process for their preparation and their use
EP0200903B1 (en) Polymeric antibacterial compositions
JPS6025410B2 (en) hair styling composition
US5451394A (en) Quaternary salts of para-dialkylamino benzamide derivatives
US4411891A (en) Cationized dextran and salts thereof and manufacturing process and utilization thereof
EP0767191A2 (en) Polymer, preparation process thereof, hairtreating compositions and cosmetic compositions
US4180084A (en) Cosmetic compositions containing polymeric quaternary ammonium salts
EP0330174B1 (en) Hair setting gel composition
US5948882A (en) Film forming antiperspirant polymers
JP3985900B2 (en) Amphiphilic cationic associative polymer, process for producing the same, use as a thickener and composition containing the same
EP0327379A2 (en) Humectants
US5352696A (en) Quaternary nitrogen-containing vitamin E derivatives and uses thereof
EP0754029B1 (en) Compositions containing film forming antiperspirant polymers
AU604812B2 (en) UV-absorbing higher alkyl quaternary ammonium salts of cinnamate esters
US6071505A (en) Cationic cellulose derivatives of controlled charge density useful in cosmetic preparations
AU740217B2 (en) Film forming antiperspirant polymers
JPH1077345A (en) Polyaspartic acid derivative soluble or dispersible in water, its production, beauty treatment assistant composed of the compound and hair-treatment composition containing the compound
EP0141269B1 (en) Modified polyvinyl alcohol polymers
US4981680A (en) P-hydroxycinnamamide derivatives and melanin inhibitor comprising the same
US5439674A (en) Hair cosmetic material
US4873293A (en) Partially hydrolyzed, poly(N-acyl alkylenimines) in personal care
MXPA96004591A (en) Antitranspirant polymers that form pelic

Legal Events

Date Code Title Description
AS Assignment

Owner name: GILLETTE COMPANY, THE (A DELAWARE CORPORATION), MA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CAUSTON, BRIAN E.;BAINES, FEDERICK C.;REEL/FRAME:008198/0507

Effective date: 19961003

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: THE GILLETTE COMPANY LLC, MASSACHUSETTS

Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:THE GILLETTE COMPANY;THE GILLETTE COMPANY LLC;REEL/FRAME:040145/0258

Effective date: 20160901